Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    15703420 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Lenalidomide
2 Completed
Has Results
Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: Lenalidomide
3 Recruiting Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone
4 Recruiting Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Lenalidomide;   Other: Placebo

Indicates status has not been verified in more than two years